Cargando…
Early Chk1 Phosphorylation Is Driven by Temozolomide-Induced, DNA Double Strand Break- and Mismatch Repair-Independent DNA Damage
Temozolomide (TMZ) is a DNA methylating agent used to treat brain cancer. TMZ-induced O6-methylguanine adducts, in the absence of repair by O6-methylguanine DNA methyltransferase (MGMT), mispair during DNA replication and trigger cycles of futile mismatch repair (MMR). Futile MMR in turn leads to th...
Autores principales: | Ito, Motokazu, Ohba, Shigeo, Gaensler, Karin, Ronen, Sabrina M., Mukherjee, Joydeep, Pieper, Russell O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646831/ https://www.ncbi.nlm.nih.gov/pubmed/23667469 http://dx.doi.org/10.1371/journal.pone.0062351 |
Ejemplares similares
-
Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021) -
Phosphorylation of Histone H2B at DNA Double-Strand Breaks
por: Fernandez-Capetillo, Oscar, et al.
Publicado: (2004) -
CBMS-02 Phosphoglycerate mutase 1 (PGAM1) controls DNA damage repair via regulation of WIP1 activity
por: Ohba, Shigeo, et al.
Publicado: (2020) -
Crosstalk between repair pathways elicits double-strand breaks in alkylated DNA and implications for the action of temozolomide
por: Fuchs, Robert P, et al.
Publicado: (2021) -
Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcoma
por: Li, Xiaoyang, et al.
Publicado: (2020)